Saulo Klahr, Jeremiah J. Morrissey Kidney International

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Current status of end-stage renal disease care in India and Pakistan

Volume 70, Issue 10, Pages (November 2006)

Cellular mechanisms of renal osteodystrophy

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Current status of end-stage renal disease care in India and Pakistan

Macrophage heterogeneity, phenotypes, and roles in renal fibrosis

Volume 56, Pages S31-S36 (July 1999)

Progression of renal failure and hypertensive nephrosclerosis

TGF-β isoforms in renal fibrogenesis

EGFR signaling in renal fibrosis

Metabolic Acidosis of CKD: An Update

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Burden of chronic kidney disease: North Africa

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Volume 66, Pages S13-S17 (September 2004)

Volume 70, Issue 7, Pages (October 2006)

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Proinflammatory effects of iron sucrose in chronic kidney disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Volume 79, Pages S20-S23 (April 2011)

Insulin resistance in African Americans

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum? Sharon J. Nessim, Jeffrey.

Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44? Sandrine Florquin,

The role of protein kinase C activation in diabetic nephropathy

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Osteopontin in diabetic nephropathy: signpost or road?

Fructose intake as a risk factor for kidney stone disease

The promise of biomarkers for personalized renal cancer care

Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target? Hatem Amer, Matthew D. Griffin Kidney International

Volume 73, Issue 12, Pages (June 2008)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

The future of renoprotection: Frustration and promises

Volume 59, Issue 3, Pages (March 2001)

Methods for guideline development

AGEs in foods: Do they play a role in uremia?

CD4+ T cells: a potential player in renal fibrosis

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives Pierre Ronco, Christos Chatziantoniou

Why is proteinuria an ominous biomarker of progressive kidney disease?

Volume 69, Issue 10, Pages (May 2006)

Opportunities for a chronic disease outreach program in China

Guang-Huar Young, Vin-Cent Wu Kidney International

Clinical benefits of slowing the progression of renal failure

Atherosclerotic nephropathy

Molecular mechanisms of renal hypertrophy: Role of p27Kip1

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Is complement a target for therapy in renal disease?

David A. Ferenbach, David C. Kluth, Jeremy Hughes Kidney International

Sandrine Billet, Fréderick Aguilar, Camille Baudry, Eric Clauser

Kathryn J. Wiggins, Darren J. Kelly Kidney International

Volume 75, Issue 7, Pages (April 2009)

Arya M. Sharma, Joachim Beige, Armin Distler Kidney International

Volume 75, Issue 6, Pages (March 2009)

Renal vascular disease in the elderly

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 74, Issue 10, Pages (November 2008)

Volume 75, Issue 8, Pages (April 2009)

Volume 57, Pages S44-S48 (April 2000)

Sugar-sweetened beverages and chronic disease

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease Saulo Klahr, Jeremiah J. Morrissey Kidney International Volume 57, Pages S7-S14 (April 2000) DOI: 10.1046/j.1523-1755.2000.07509.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Role of angiotensin II in the progression of chronic renal disease. Kidney International 2000 57, S7-S14DOI: (10.1046/j.1523-1755.2000.07509.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Pathogenesis of interstitial fibrosis. Abbreviations are: ECM, extracellular matrix; TGF-β1, transforming growth factor-β1; ↑, increase; ↓, decrease. Kidney International 2000 57, S7-S14DOI: (10.1046/j.1523-1755.2000.07509.x) Copyright © 2000 International Society of Nephrology Terms and Conditions